Tissue selective drug delivery utilizing carrier-mediated transport systems (Q40923431)

24 September 2017

Tissue selective drug delivery utilizing carrier-mediated transport systems (English)

1 reference

24 September 2017

1 reference

Tsuji A

1

1 reference

PubMed ID

10518656

24 September 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

Journal of Controlled Release

24 September 2017

1 reference

24 September 2017

62

1 reference

24 September 2017

1-2

1 reference

24 September 2017

239-244

1 reference

Carrier-mediated intestinal transport of drugs

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900043-7

7 January 2021

Drug delivery through the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900043-7

7 January 2021

Human intestinal H+/peptide cotransporter. Cloning, functional expression, and chromosomal localization

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900043-7

7 January 2021

Immunolocalization and pharmacological relevance of oligopeptide transporter PepT1 in intestinal absorption of beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900043-7

7 January 2021

The predominant contribution of oligopeptide transporter PepT1 to intestinal absorption of beta-lactam antibiotics in the rat small intestine.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900043-7

7 January 2021

Uptake of clarithromycin by rat lung cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900043-7

7 January 2021

A pharmacokinetic analysis program (multi) for microcomputer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900043-7

7 January 2021

Expression cloning of a mammalian proton-coupled oligopeptide transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900043-7

7 January 2021

Active Transport of L-Dopa in the Intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900043-7

7 January 2021

Mechanism of absorption of the dipeptide alpha-methyldopa-phe in intestinal brush-border membrane vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900043-7

7 January 2021

Intestinal absorption studies on peptide mimetic alpha-methyldopa prodrugs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900043-7

7 January 2021

Improvement of L-dopa absorption by dipeptidyl derivation, utilizing peptide transporter PepT1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900043-7

7 January 2021

In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900043-7

7 January 2021

Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900043-7

7 January 2021

Proton-cotransport of pravastatin across intestinal brush-border membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900043-7

7 January 2021

In-vitro evidence for carrier-mediated uptake of acidic drugs by isolated bovine brain capillaries.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900043-7

7 January 2021

Carrier-mediated uptake of pravastatin by rat hepatocytes in primary culture

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900043-7

7 January 2021

10.1016/S0168-3659(99)00043-7

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

10518656